This Biotech Stock Could Be the Best Investment of the Decade

Picking stocks with a relatively narrow timeframe in mind -- and with a particular performance expectation -- can be tricky. Most investors can distinguish between bad, good, and even-better investment prospects. But it's impossible to know exactly how well a stock will perform, or when it will perform well. That's why Warren Buffett's favorite holding period is simply "forever."However, every now and then, the proverbial planets line up. That is to say, it becomes clear that a company is on the cusp of massive and sustained growth, with its stock poised to follow suit.Iovance Biotherapeutics (NASDAQ: IOVA) is one such company right now, entering a decade of incredible growth. Here's why aggressive investors might want to use the stock's recent weakness as a buying opportunity.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool